Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
TFF Pharmaceuticals, Inc. TFFP
$0.72
+$0.05 (7.45%)
На 18:02, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
27144825.00000000
-
week52high
6.73
-
week52low
0.53
-
Revenue
0
-
P/E TTM
0
-
Beta
1.18190000
-
EPS
-1.13000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 10:59
Описание компании
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various pain; Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| B. Riley Securities | Buy | Buy | 29 мар 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 05 мар 2021 г. |
| HC Wainwright & Co. | Buy | 08 февр 2021 г. | |
| Maxim Group | Buy | 08 июл 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| ROCAMBOLI STEPHEN | A | 33475 | 33475 | 29 дек 2022 г. |
| Roberts Brandi | A | 20968 | 20968 | 29 дек 2022 г. |
| Fletcher Aaron G.L. | A | 33475 | 33475 | 29 дек 2022 г. |
| MILLS ROBERT S | A | 33475 | 33475 | 29 дек 2022 г. |
| Weisman Harlan F | A | 64615 | 50000 | 15 дек 2022 г. |
| Weisman Harlan F | A | 1792450 | 1792450 | 03 дек 2022 г. |
| Fletcher Aaron G.L. | A | 21735 | 21735 | 22 ноя 2022 г. |
| Fletcher Aaron G.L. | A | 143470 | 43470 | 22 ноя 2022 г. |
| THURMAN RANDY H | D | 84670 | 40255 | 29 сент 2022 г. |
| THURMAN RANDY H | D | 0 | 40255 | 29 сент 2022 г. |
Новостная лента
Best Penny Stocks To Buy Now? 7 Insider Picks In November
PennyStocks
25 ноя 2022 г. в 09:43
7 penny stock picks from insiders in November 2022 The post Best Penny Stocks To Buy Now? 7 Insider Picks In November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy Now? 4 Insider Picks In November
PennyStocks
23 ноя 2022 г. в 10:05
Penny stock picks from insiders in November 2022. The post Best Penny Stocks To Buy Now?
TFF Pharmaceuticals: From Undefeatable To Speculative
Seeking Alpha
22 ноя 2022 г. в 22:42
Almost everything has gone wrong since my first bullish article with TFF Pharmaceuticals. The stock is now severely depressed and, despite significant dilution, a case can be made for a speculative long position.
TFF Pharmaceuticals, Inc. (TFFP) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 22:31
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO & Director Dale Christensen - Head, Clinical Development Kirk Coleman - CFO, Treasurer & Secretary Robert Williams - Technology Inventor & Special Advisor Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Vernon Bernardino - H.C. Wainwright & Co. Michael Okunewitch - Maxim Group Operator Greetings, and welcome to the TFF Pharmaceuticals, Inc. Third Quarter 2022 Earnings Conference Call.
TFF Pharmaceuticals to Participate at The H.C. Wainwright 24th Annual Global Investment Conference
GlobeNewsWire
06 сент 2022 г. в 08:00
FORT WORTH, Texas, Sept. 06, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will be participating in the H.C. Wainwright 24th Annual Global Investment Conference being held September 12 – 14, 2022 at the Lotte New York Palace in New York City. Company management will also be participating in one-on-one meetings throughout the conference.